← Back to Search

Suicide Prevention Program for Suicidal and Self-Harm Behaviour

N/A
Waitlist Available
Led By Brian R Shiner, MD, MPH
Research Sponsored by White River Junction Veterans Affairs Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from baseline aes at 1- and 6-months
Awards & highlights

Study Summary

This trial evaluates the effect of a suicide prevention intervention during high risk transition periods, such as discharge from an emergency room.

Eligible Conditions
  • Suicidal and Self-Harm Behaviour

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from baseline bss at 1-, 3-, and 6-months
This trial's timeline: 3 weeks for screening, Varies for treatment, and change from baseline bss at 1-, 3-, and 6-months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
The Beck Scale for Suicidal Ideation (BSS)
Secondary outcome measures
App Engagement Scale (AES)
Columbia Suicide Severity Rating Scale (C-SSRS)
Interpersonal Needs Questionnaire 15 (INQ-15)
+4 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Suicide Prevention ProgramExperimental Treatment1 Intervention
Group II: Usual CareActive Control1 Intervention

Find a Location

Who is running the clinical trial?

White River Junction Veterans Affairs Medical CenterLead Sponsor
28 Previous Clinical Trials
16,821 Total Patients Enrolled
US Department of Veterans AffairsFED
868 Previous Clinical Trials
487,830 Total Patients Enrolled
Brian R Shiner, MD, MPHPrincipal InvestigatorWhite River Junction Veterans Affairs Medical Center

Media Library

Suicidal and Self-Harm Behaviour Research Study Groups: Suicide Prevention Program, Usual Care
Suicidal and Self-Harm Behaviour Clinical Trial 2023: Suicide Prevention Program Highlights & Side Effects. Trial Name: NCT04054947 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are any new participants being accepted into this experiment?

"According to the information on clinicaltrials.gov, recruitment for this medical trial is not presently taking place. The study was initially posted in October of 2019 and last revised in October 2022, although over 190 other trials are actively seeking participants at present."

Answered by AI
~11 spots leftby Apr 2025